X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,335,604 | -43.8% | 14,986,793 | 0.0% | 1.26% | -43.1% |
| Q2 2023 | $29,074,378 | +184.7% | 14,986,793 | +27.7% | 2.22% | +214.3% |
| Q1 2023 | $10,211,010 | -12.4% | 11,736,793 | 0.0% | 0.71% | +7.8% |
| Q4 2022 | $11,654,635 | +4.5% | 11,736,793 | +79.9% | 0.66% | +17.6% |
| Q3 2022 | $11,155,000 | +234.7% | 6,523,157 | +1856.9% | 0.56% | +220.1% |
| Q1 2020 | $3,333,000 | -6.6% | 333,333 | 0.0% | 0.17% | +3.0% |
| Q4 2019 | $3,567,000 | -15.8% | 333,333 | 0.0% | 0.17% | -51.9% |
| Q3 2019 | $4,237,000 | -15.3% | 333,333 | 0.0% | 0.35% | +0.3% |
| Q2 2019 | $5,000,000 | -13.8% | 333,333 | 0.0% | 0.35% | +16.3% |
| Q1 2019 | $5,803,000 | – | 333,333 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 311,490 | $532,000 | 1.65% |
| Bain Capital Life Sciences Investors, LLC | 6,389,436 | $10,926,000 | 1.30% |
| Tri Locum Partners LP | 2,504,006 | $4,282,000 | 1.18% |
| Sio Capital Management, LLC | 1,418,461 | $2,426,000 | 0.77% |
| NEA Management Company, LLC | 6,523,157 | $11,155,000 | 0.56% |
| AIGH Capital Management LLC | 997,719 | $1,706,000 | 0.53% |
| Parkman Healthcare Partners LLC | 950,000 | $1,625,000 | 0.46% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $573,000 | 0.34% |
| Worth Venture Partners, LLC | 250,144 | $428,000 | 0.26% |
| Ikarian Capital, LLC | 568,612 | $973,000 | 0.19% |